The diagnostic value of cytokeratin 19 fragment in non small-cell lung cancer
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3969/j.issn.1673-4130.2014.19.018
   		
        
        	
        		- VernacularTitle:血清细胞角蛋白19片段对非小细胞肺癌的诊断价值
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Changzheng LIAO
			        		
			        		;
		        		
		        		
		        		
			        		Yi LUO
			        		
			        		;
		        		
		        		
		        		
			        		Wenli XU
			        		
			        		;
		        		
		        		
		        		
			        		Shengxiao WEI
			        		
			        		;
		        		
		        		
		        		
			        		Lei ZHU
			        		
			        		;
		        		
		        		
		        		
			        		Ruihuan XU
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		cytokeratin 19 fragment;
			        		
			        		
			        		
				        		reference interval;
			        		
			        		
			        		
				        		non-small cell lung cancer;
			        		
			        		
			        		
				        		receiver operating characteristic curve
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			International Journal of Laboratory Medicine
	            		
	            		 2014;(19):2616-2617
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To discuss the diagnostic value of cytokeratin 19 fragment(CYFRA21-1) in non small-cell lung cancer (NSCLC) .Methods The serum CYFRA21-1 levels were tested in 1 046 healthy adults(healthy group) ,244 benign pulmonary dis-ease patients(benign disease group) and 90 NSCLC patients(NSCLC group) .The results were analyzed statistically .Results There was not significantly difference between man and women in healthy group for CYFRA21-1 level(P>0 .05) .The CYFRA21-1 level in more than 60 years cases was obviously higher than that in less than 18-40 years group and >40-60 group .The upper limit of serum CYFRA21-1 was 4 .00 ng/mL according 95% confidence interval of benign disease group .A cut-off value of 4 .70 ng/mL in NSCLC group was suggested when compared with receiver operating characteristic curve(ROC curve) ,and its sensitivity and speci-ficity were 62 .1% and 92 .6% respectively .Conclusion The diagnostic value for serum CYFRA21-1 in NSCLC was 4 .70 ng/mL .